Usana Health Sciences Inc's Chief Legal Officer Joshua Foukas Sells Company Shares
Usana Health Sciences Inc (NYSE:USNA), a company specializing in the development and manufacture of science-based nutritional and personal care products, has reported an insider sale according to a recent SEC filing. Chief Legal Officer Joshua Foukas sold 4,847 shares of the company on February 29, 2024. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this SEC Filing.
Over the past year, the insider has sold a total of 4,847 shares of Usana Health Sciences Inc and has not made any purchases of the stock. The company's insider transaction history over the past year shows a total of 20 insider sells and no insider buys.
On the date of the insider's most recent transaction, shares of Usana Health Sciences Inc were trading at $47.91, giving the company a market capitalization of $944.134 million. The stock's price-earnings ratio stands at 14.87, which is below both the industry median of 18.54 and the company's historical median price-earnings ratio.
According to the GuruFocus Value assessment, with a share price of $47.91 and a GF Value of $59.67, Usana Health Sciences Inc's price-to-GF-Value ratio is 0.8, indicating that the stock is considered Modestly Undervalued. The GF Value is a proprietary intrinsic value estimate from GuruFocus, which factors in historical trading multiples, a GuruFocus adjustment factor based on the company's past performance, and future business performance estimates from Morningstar analysts.
The insider trend image above reflects the recent selling activity by insiders of Usana Health Sciences Inc.
The GF Value image provides a visual representation of the stock's current valuation in relation to its GuruFocus Value.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
